Dronedarone: A New Therapeutic Alternative for Cardiac Arrhythmias
2010

Dronedarone: A New Treatment for Heart Rhythm Problems

publication Evidence: moderate

Author Information

Author(s): Upaganlawar A, Gandhi H, Balaraman R

Primary Institution: Department of Pharmacy, Faculty of Technology and Engineering, MS University of Baroda

Hypothesis

Is dronedarone a safe and effective treatment for cardiac arrhythmias?

Conclusion

Dronedarone can help maintain normal heart rhythms but is associated with increased death rates in patients with heart failure.

Supporting Evidence

  • Dronedarone was approved by the FDA for treating cardiac arrhythmias.
  • It is less lipophilic than amiodarone, leading to a smaller volume of distribution.
  • Trials showed better maintenance of sinus rhythm with dronedarone compared to placebo.
  • Adverse effects include nausea, diarrhea, rash, and creatinine elevation.

Takeaway

Dronedarone is a new medicine that helps keep the heart beating normally, but it can be dangerous for some people with heart problems.

Methodology

The text discusses the pharmacokinetics and clinical trials of dronedarone.

Potential Biases

The ANDROMEDA trial was stopped early due to increased mortality, indicating potential bias in patient selection.

Limitations

The trials included patients with varying degrees of heart failure, which may affect the results.

Participant Demographics

Patients with moderate to severe congestive heart failure were included in the ANDROMEDA trial.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication